J. C. Bendell, et al., “Randomized Phase II Study of Perifosine in combination with Capecitabine (P-CAP) versus Capecitabine Plus Placebo (CAP) in Patients with second- or Third-line Metastatic Colon Cancer (mCRC): Updated Results,” Gastrointestinal Cancers Symposium, Orland, 22-24 January 2010.
Related Articles:
A Multicenter Cohort Study for XELOX (Capecitabine, Leucovorin plus Oxaliplatin) Therapy as First-Line Treatment in Elderly Patients with Unresectable Colorectal Cancer
Tetsu Yamamoto, Ryoji Hyakudomi, Shinichi Sugimoto, Atsuo Tokuka, Yoshitoshi Sato, Satoshi Nagai, Hikota Hayashi, Masahikoo Igarashi, Kenji Takubo, Yoshitsugu Tajima
DOI:
10.4236/jct.2015.62017
3,041 Downloads 3,552 Views Citations
Pub. Date:
February
4,
2015
Rationale and Study Protocol of the J-SAVER Study: A Phase II Study of S-1 on Alternate Days Combined with Bevacizumab in Patients Aged ≥75 Years with Metastatic Colorectal Cancer
Toshikazu Moriwaki, Tetsuya Eto, Akihito Tsuji, Nobushige Kakinoki, Mitsuo Shimada, Takashi Maeba, Hiroaki Hatano, Ikuo Takahashi, Hiroyasu Ishida, Kazuho Ikeda, Yoshiaki Bando, Ichinosuke Hyodo
DOI:
10.4236/jct.2017.811088
638 Downloads 1,175 Views Citations
Pub. Date:
November
28,
2017
